Solventum Corporation
SOLV
$71.14
-$2.38-3.24%
NYSE
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | 2.07B | 2.08B | 2.08B | 2.08B | 2.02B |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 2.07B | 2.08B | 2.08B | 2.08B | 2.02B |
Cost of Revenue | 946.00M | 937.00M | 917.00M | 944.00M | 844.00M |
Gross Profit | 1.12B | 1.14B | 1.17B | 1.14B | 1.17B |
SG&A Expenses | 774.00M | 748.00M | 704.00M | 701.00M | 596.00M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 1.91B | 1.88B | 1.81B | 1.84B | 1.64B |
Operating Income | 160.00M | 198.00M | 272.00M | 244.00M | 381.00M |
Income Before Tax | 38.00M | 14.00M | 167.00M | 96.00M | 329.00M |
Income Tax Expenses | -99.00M | -17.00M | 45.00M | 7.00M | 92.00M |
Earnings from Continuing Operations | 137.00M | 31.00M | 122.00M | 89.00M | 237.00M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 137.00M | 31.00M | 122.00M | 89.00M | 237.00M |
EBIT | 160.00M | 198.00M | 272.00M | 244.00M | 381.00M |
EBITDA | 289.00M | 348.00M | 405.00M | 377.00M | 520.00M |
EPS Basic | 0.79 | 0.18 | 0.70 | 0.51 | 1.37 |
Normalized Basic EPS | 0.20 | 0.27 | 0.60 | 0.35 | 1.19 |
EPS Diluted | 0.78 | 0.18 | 0.70 | 0.51 | 1.37 |
Normalized Diluted EPS | 0.20 | 0.27 | 0.60 | 0.35 | 1.19 |
Average Basic Shares Outstanding | 173.70M | 173.40M | 173.40M | 173.20M | 172.70M |
Average Diluted Shares Outstanding | 174.80M | 174.50M | 173.90M | 173.50M | 172.70M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |